Skip to content
Screener

Precigen PGEN Common Stock Shares Issued

Common Stock Shares Issued at other companies

Gilead Sciences logo
Gilead SciencesGILD
1.2B-0.1%
Allogene Therapeutics logo
Allogene TherapeuticsALLO
244.8M+12.0%
ALN
Alnylam PharmaceuticalsALNY
133.7M+2.1%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
29.5M-84.8%

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$2.51B+388%
Enterprise value$2.6B+414%
P/S94.4×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The source filing: Precigen’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 4:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001356090-26-000017
(Amounts in thousands, except share data)March 31,2026December 31,2025
Total liabilities118,392134,594
Commitments and contingencies (Note 14)
Shareholders' equity
Common stock, no par value, 700,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 355,903,977 shares and 353,910,926 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively.
Additional paid-in capital2,369,5292,362,252
Accumulated deficit(2,349,277)(2,341,348)
Accumulated other comprehensive (loss) income(17)7
Total shareholders' equity20,23520,911

Item 1. Condensed Consolidated Financial Statements

FAQ

What is Precigen's common stock shares issued?
Precigen (PGEN) reported common stock shares issued of 355.9M in Q1 2026.
How has Precigen's common stock shares issued changed year-over-year?
Precigen's common stock shares issued increased by 20.6% year-over-year, from 295.1M to 355.9M.
What is the long-term trend for Precigen's common stock shares issued?
Over 5 years (2020 to 2025), Precigen's common stock shares issued has grown at a 13.5% compound annual growth rate (CAGR), from 187.7M to 353.9M.
What does common stock shares issued mean?
The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.

Ask your AI about Precigen's common stock shares issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude